BRIDGEWATER, N.J., and BENGALURU, India, Jan. 9, 2025 /PRNewswire/ -- Biocon Biologics Ltd (BBL ... markets that's currently serving over 5 million patients worldwide. The Company's strong ...

Ratings for Eton Pharmaceuticals (NASDAQ:ETON) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments ...

Indian pharmaceutical companies are projected to achieve a revenue growth of 9-11% in FY25. This growth is expected to be fueled by robust performances in key markets, including the United States, ...

This approval broadens Biocon’s portfolio of complicated medicinal products and reinforces its position in the global pharmaceutical ... declined 7.6% to ₹685.5 Crore in the second quarter ...

Biocon Ltd has hired more top executives in ... Mankind Pharma aims to strengthen its position in the pharmaceutical industry by focusing on quality, affordability, and accessibility.

Creador is banking on MG’s low-cost platform to shake up key markets like North Asia and Europe. The challenge? Scaling globally while keeping MG’s lean and efficient DNA intact. Creador has ...

ACADIA Pharmaceuticals has a 12-month low of $14.15 and a 12-month high of $31.82. Get ACADIA Pharmaceuticals alerts: ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) last announced its ...

Most of these innovations have been done by smaller companies, and R&D efforts by the biggest pharmaceutical companies have often been not very successful. Nevertheless, the pharmaceutical industry is ...